CLINICAL_TRIALS
trial_result
· 2012-10-26
Clinical Trial Update: Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Phase 3]
Summary
Phase 3 trial comparing insulin lispro vs insulin aspart for six days in pump therapy for Type 1 diabetes has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2012-10-26